Clinical Trials Browser

Completed × Lymphoma, Follicular × ofatumumab × Clear all

NCT02710643 2022-06-21

FIL_MIRO

Phase 2 Completed

Lymphoma, Lymphoma, Follicular

NCT01190449 2021-08-18

Ofatumumab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Phase 2 Completed

51 enrolled 7 charts

Lymphoma, Lymphoma, Follicular

NCT00742144 2017-11-17

Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia, Lymphoma, Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00494780 2014-07-11

MUNIN

Phase 2 Completed

59 enrolled 21 charts

Lymphoma, Follicular

NCT00394836 2014-01-29

HuMax-CD20 i(Ofatumumab) n Follicular Lymphoma (FL) Patients Refractory to Rituximab

Phase 2 Completed

116 enrolled 22 charts

Lymphoma, Follicular